Figure 2.
Receiver operating characteristic (ROC) curve analysis comparing genomic classifier (GC) with (a) individual clinicopathologic factors and (b) clinical models and genomic-clinical models for predicting clinical metastasis at 3 years post biochemical recurrence (BCR). AUC, area under the ROC curve; ECE, extra-capsular extension; GS, Gleason score; SM, surgical margin; SVI, seminal vesicle invasion.
